537 related articles for article (PubMed ID: 26081992)
21. shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells.
Xu Y; Hu YD; Zhou J; Zhang MH; Yuan WW; Luo Y
Oncol Rep; 2012 Aug; 28(2):629-39. PubMed ID: 22664532
[TBL] [Abstract][Full Text] [Related]
22. Lung cancer stem cells: The root of resistance.
MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
Cancer Lett; 2016 Mar; 372(2):147-56. PubMed ID: 26797015
[TBL] [Abstract][Full Text] [Related]
23. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
24. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy.
Ren JH; He WS; Nong L; Zhu QY; Hu K; Zhang RG; Huang LL; Zhu F; Wu G
Cancer Biother Radiopharm; 2010 Feb; 25(1):75-80. PubMed ID: 20187799
[TBL] [Abstract][Full Text] [Related]
25. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
Ma L; Lai D; Liu T; Cheng W; Guo L
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
[TBL] [Abstract][Full Text] [Related]
26. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.
Hiraga T; Ito S; Nakamura H
Oncol Rep; 2011 Jan; 25(1):289-96. PubMed ID: 21109989
[TBL] [Abstract][Full Text] [Related]
27. [Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells].
He J; Song X; Yu L; Li J; Qiao Z; Jiu R; Yu B; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):625-9. PubMed ID: 25940289
[TBL] [Abstract][Full Text] [Related]
28. MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6.
Yang L; Lin Z; Wang Y; Gao S; Li Q; Li C; Xu W; Chen J; Liu T; Song Z; Liu G
Mol Carcinog; 2018 Mar; 57(3):419-428. PubMed ID: 29144562
[TBL] [Abstract][Full Text] [Related]
29. Synergistic Roles of Curcumin in Sensitising the Cisplatin Effect on a Cancer Stem Cell-Like Population Derived from Non-Small Cell Lung Cancer Cell Lines.
Abdul Satar N; Ismail MN; Yahaya BH
Molecules; 2021 Feb; 26(4):. PubMed ID: 33670440
[TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells.
Sun FF; Hu YH; Xiong LP; Tu XY; Zhao JH; Chen SS; Song J; Ye XQ
Int J Clin Exp Pathol; 2015; 8(6):6287-300. PubMed ID: 26261505
[TBL] [Abstract][Full Text] [Related]
31. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction.
Huang JS; Yao CJ; Chuang SE; Yeh CT; Lee LM; Chen RM; Chao WJ; Whang-Peng J; Lai GM
BMC Cancer; 2016 Mar; 16():245. PubMed ID: 27012679
[TBL] [Abstract][Full Text] [Related]
32. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
33. Identification of stem-like cells in non-small cell lung cancer cells with specific peptides.
Wang A; Chen L; Pu K; Zhu Y
Cancer Lett; 2014 Aug; 351(1):100-7. PubMed ID: 24846302
[TBL] [Abstract][Full Text] [Related]
34. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
[TBL] [Abstract][Full Text] [Related]
35. Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells.
Wang X; Liu Q; Hou B; Zhang W; Yan M; Jia H; Li H; Yan D; Zheng F; Ding W; Yi C; Hai Wang
PLoS One; 2013; 8(9):e73942. PubMed ID: 24040121
[TBL] [Abstract][Full Text] [Related]
36. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.
Su J; Wu S; Tang W; Qian H; Zhou H; Guo T
Mol Carcinog; 2016 Nov; 55(11):1822-1832. PubMed ID: 26513225
[TBL] [Abstract][Full Text] [Related]
37. Profiling of apoptosis- and autophagy-associated molecules in human lung cancer A549 cells in response to cisplatin treatment using stable isotope labeling with amino acids in cell culture.
Wang Z; Liu G; Jiang J
Int J Oncol; 2019 Mar; 54(3):1071-1085. PubMed ID: 30664195
[TBL] [Abstract][Full Text] [Related]
38. MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells.
Yin B; Zeng Y; Liu G; Wang X; Wang P; Song Y
Int J Clin Exp Pathol; 2014; 7(6):2934-41. PubMed ID: 25031712
[TBL] [Abstract][Full Text] [Related]
39. Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer.
Ma Y; Li M; Si J; Xiong Y; Lu F; Zhang J; Zhang L; Zhang P; Yang Y
Int J Oncol; 2016 Jun; 48(6):2349-58. PubMed ID: 27035162
[TBL] [Abstract][Full Text] [Related]
40. Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma.
Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
Mol Med Rep; 2015 Sep; 12(3):4352-4357. PubMed ID: 26081022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
